Tetrazole derivatives
US-2024382468-A2 · Nov 21, 2024 · US
Amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
US9303019B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9303019-B2 |
| Application number | US-201214112631-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 17, 2012 |
| Priority date | Apr 19, 2011 |
| Publication date | Apr 5, 2016 |
| Grant date | Apr 5, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Novel amino-pyrrolinic derivatives, their pharmacologically acceptable salts and use thereof in the prevention and/or treatment of metabolic syndrome.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound of following general formula (I): wherein: a) R12 represents H, and R1 and R2 each independently are: a halogen, straight-chain or branched C1 to C8 alkyl, C2-C8 alkene, straight-chain or branched C1 to C8 alkoxy, C3-C6 cycloalkyl, C5-C6 bicycloalkyl, a polyether chain, C1-C5 perfluoroalkyl, C1-C8 acyl, OH, SH, a primary, seconda…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
- C07D403/04Primary
Chemistry & Metallurgy · mapped topic
- C07D207/22Primary
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9303019B2 cover?
- Novel amino-pyrrolinic derivatives, their pharmacologically acceptable salts and use thereof in the prevention and/or treatment of metabolic syndrome.
- Who is the assignee on this patent?
- Bousquet Pascal, Ehrhardt Jean Daniel, Fellmann Lyne, and 7 more
- What technology area does this patent fall under?
- Primary CPC classification C07D403/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).